Posts by: Steve Bryson PhD

Steve Bryson PhD

Steve holds a PhD in Biochemistry from the Faculty of Medicine at the University of Toronto, Canada. He worked as a medical scientist for 18 years, within both industry and academia, where his research focused on the discovery of new medicines to treat inflammatory disorders and infectious diseases. Steve recently stepped away from the lab and into science communications, where he’s helping make medical science information more accessible for everyone.

October 14, 2020October 14, 2020

Nerve Injury Progressing in Top-down Manner Evident in Bulbar ALS

News

Most people with bulbar onset amyotrophic lateral sclerosis (ALS) showed distinct signs of motor neuron injury starting in the bulbar region of the brain that controls swallowing and speaking, ... Read more

October 12, 2020October 12, 2020

BrainStorm Details Phase 3 Trial Design of NurOwn for Rapidly Progressing ALS

News

BrainStorm Cell Therapeutics is sharing the details of the design of its Phase 3 clinical trial evaluating NurOwn as a treatment for people with rapidly progressing amyotrophic lateral sclerosis ... Read more

October 7, 2020October 7, 2020

MDA Issues $1.6M in Grants to Boost ALS Research

News

The Muscular Dystrophy Association (MDA) has awarded five new grants totaling more than $1.6 million to boost research of amyotrophic lateral sclerosis (ALS). These grants add to the $168 million ... Read more

October 2, 2020October 2, 2020

Saphyr Technology First to Measure DNA Expansions in Key ALS Gene

News

Saphyr, an ultra-long DNA analysis technology by Bionano Genomics, is the first to successfully measure very large repeat expansions in the C9ORF72 gene, the underlying cause of some amyotrophic ... Read more

September 30, 2020September 30, 2020

Large Genetic Analysis Newly Links 5 Genes to Sporadic ALS

News

A combined analysis using people of Japanese, Chinese, and European ancestry identified five new genes associated with the non-familial, sporadic form of amyotrophic lateral sclerosis (ALS). These findings further an ... Read more

August 11, 2020August 12, 2020

Aural Analytics’ Speech Technology Added to HEALEY ALS Platform Trial

News

Aural Analytics’ speech-based digital technology will be used to measure changes in speech in people with amyotrophic lateral sclerosis (ALS) as endpoints for the HEALEY ALS Platform Trial, which ... Read more

August 3, 2020August 4, 2020

Stem Cell Treatment Seen to Safely Aid Speech in ALS Patients in Small Study

News

Stem cells collected from a patient’s bone marrow and infused into the spinal fluid safely improved speaking abilities after 28 days for most of the 12 adults with amyotrophic lateral ... Read more

July 31, 2020August 3, 2020

Study Probes Gut Microbiome Alterations, Probiotics in ALS Patients

News

The gut microbiome in people with amyotrophic lateral sclerosis (ALS) is altered compared to healthy people, which includes an imbalance in potentially protective microbial groups and others with pro-inflammatory ... Read more

July 23, 2020July 24, 2020

Common Blood Biomarker Changes Linked to ALS Progression, Study Determines

News

Changes in commonly tested blood biomarkers in people with amyotrophic lateral sclerosis (ALS) may be associated with faster disease progression and an increased risk of mortality, according to a ... Read more

July 20, 2020July 20, 2020

Slower Progression Seen in US Veterans Living Longer Than Disease Norm

News

A comparison of amyotrophic lateral sclerosis (ALS) among U.S. military veterans found those who lived the longest with this disease — an average of 16.3 years in more than ... Read more

Pin It on Pinterest